208 related articles for article (PubMed ID: 7678586)
21. IgG subclass response to immunization with Haemophilus influenzae type b polysaccharide-outer membrane protein conjugate vaccine.
Granoff DM; Weinberg GA; Shackelford PG
Pediatr Res; 1988 Aug; 24(2):180-5. PubMed ID: 3263612
[TBL] [Abstract][Full Text] [Related]
22. Randomized trial to assess immunogenicity and safety of Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine in infants.
Marchant CD; Miller JM; Marshall GS; Blatter M; Aris E; Friedland LR; Boutriau D;
Pediatr Infect Dis J; 2010 Jan; 29(1):48-52. PubMed ID: 20035207
[TBL] [Abstract][Full Text] [Related]
23. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants.
Dashefsky B; Wald E; Guerra N; Byers C
Pediatrics; 1990 Apr; 85(4 Pt 2):682-9. PubMed ID: 2107519
[TBL] [Abstract][Full Text] [Related]
24. Co-administration of a novel Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine does not interfere with the immune response to antigens contained in infant vaccines routinely used in the United States.
Marshall GS; Marchant CD; Blatter M; Friedland LR; Aris E; Miller JM
Hum Vaccin; 2011 Feb; 7(2):258-64. PubMed ID: 21307655
[TBL] [Abstract][Full Text] [Related]
25. Oligosaccharide-protein conjugate vaccines induce and prime for oligoclonal IgG antibody responses to the Haemophilus influenzae b capsular polysaccharide in human infants.
Insel RA; Anderson PW
J Exp Med; 1986 Feb; 163(2):262-9. PubMed ID: 3484778
[TBL] [Abstract][Full Text] [Related]
26. Vaccine antigen interactions after a combination diphtheria-tetanus toxoid-acellular pertussis/purified capsular polysaccharide of Haemophilus influenzae type b-tetanus toxoid vaccine in two-, four- and six-month-old infants.
Pichichero ME; Latiolais T; Bernstein DI; Hosbach P; Christian E; Vidor E; Meschievitz C; Daum RS
Pediatr Infect Dis J; 1997 Sep; 16(9):863-70. PubMed ID: 9306481
[TBL] [Abstract][Full Text] [Related]
27. Immunogenicity of Haemophilus influenzae type b polysaccharide-tetanus toxoid conjugate vaccine in infants.
Holmes SJ; Fritzell B; Guito KP; Esbenshade JF; Blatter MM; Reisinger KS; Keyserling HL; Rothstein EP; Bernstein HH; Feldman S
Am J Dis Child; 1993 Aug; 147(8):832-6. PubMed ID: 8352217
[TBL] [Abstract][Full Text] [Related]
28. Safety and immunogenicity of PRP-T combined with DTP: excretion of capsular polysaccharide and antibody response in the immediate post-vaccination period.
Miller MA; Meschievitz CK; Ballanco GA; Daum RS
Pediatrics; 1995 Apr; 95(4):522-7. PubMed ID: 7700752
[TBL] [Abstract][Full Text] [Related]
29. Synthetic oligodeoxynucleotide containing CpG motif induces an anti-polysaccharide type 1-like immune response after immunization of mice with Haemophilus influenzae type b conjugate vaccine.
von Hunolstein C; Teloni R; Mariotti S; Recchia S; Orefici G; Nisini R
Int Immunol; 2000 Mar; 12(3):295-303. PubMed ID: 10700464
[TBL] [Abstract][Full Text] [Related]
30. Depression of anticapsular antibody after immunization with Haemophilus influenzae type b polysaccharide-diphtheria conjugate vaccine.
Marchant CD; Band E; Froeschle JE; McVerry PH
Pediatr Infect Dis J; 1989 Aug; 8(8):508-11. PubMed ID: 2788860
[TBL] [Abstract][Full Text] [Related]
31. Antibodies against Haemophilus influenzae type b capsular polysaccharide and tetanus toxoid before and after a booster dose of the carrier protein nine years after primary vaccination with a protein conjugate vaccine.
Claesson BA; Trollfors B; Lagergård T; Knutsson N; Schneerson R; Robbins JB
Pediatr Infect Dis J; 2005 May; 24(5):463-4. PubMed ID: 15876951
[TBL] [Abstract][Full Text] [Related]
32. Impaired antibody response to Haemophilus influenzae type b polysaccharide and low IgG2 and IgG4 concentrations in Apache children.
Siber GR; Santosham M; Reid GR; Thompson C; Almeido-Hill J; Morell A; deLange G; Ketcham JK; Callahan EH
N Engl J Med; 1990 Nov; 323(20):1387-92. PubMed ID: 2233905
[TBL] [Abstract][Full Text] [Related]
33. Frequent nasal administrations of recombinant cholera toxin B subunit (rCTB)-containing tetanus and diphtheria toxoid vaccines induced antigen-specific serum and mucosal immune responses in the presence of anti-rCTB antibodies.
Yasuda Y; Isaka M; Taniguchi T; Zhao Y; Matano K; Matsui H; Morokuma K; Maeyama J; Ohkuma K; Goto N; Tochikubo K
Vaccine; 2003 Jun; 21(21-22):2954-63. PubMed ID: 12798639
[TBL] [Abstract][Full Text] [Related]
34. Effect of carrier priming on immunogenicity of saccharide-protein conjugate vaccines.
Peeters CC; Tenbergen-Meekes AM; Poolman JT; Beurret M; Zegers BJ; Rijkers GT
Infect Immun; 1991 Oct; 59(10):3504-10. PubMed ID: 1894357
[TBL] [Abstract][Full Text] [Related]
35. Avidity and bactericidal activity of antibody elicited by different Haemophilus influenzae type b conjugate vaccines. The Vaccine Study Group.
Schlesinger Y; Granoff DM
JAMA; 1992 Mar; 267(11):1489-94. PubMed ID: 1538539
[TBL] [Abstract][Full Text] [Related]
36. Murine immune responses to Neisseria meningitidis group C capsular polysaccharide and a thymus-dependent toxoid conjugate vaccine.
Rubinstein LJ; García-Ojeda PA; Michon F; Jennings HJ; Stein KE
Infect Immun; 1998 Nov; 66(11):5450-6. PubMed ID: 9784556
[TBL] [Abstract][Full Text] [Related]
37. Suppression and modulation of cellular and humoral immune responses to Haemophilus influenzae type B (Hib) conjugate vaccine in hib-diphtheria-tetanus toxoids-acellular pertussis combination vaccines: a study in a rat model.
Mawas F; Newman G; Burns S; Corbel MJ
J Infect Dis; 2005 Jan; 191(1):58-64. PubMed ID: 15593004
[TBL] [Abstract][Full Text] [Related]
38. Impact of Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine on responses to concurrently administered diphtheria-tetanus-pertussis vaccine.
Clemens JD; Ferreccio C; Levine MM; Horwitz I; Rao MR; Edwards KM; Fritzell B
JAMA; 1992 Feb; 267(5):673-8. PubMed ID: 1731134
[TBL] [Abstract][Full Text] [Related]
39. Responses of children to booster immunization with their primary conjugate Haemophilus influenzae type B vaccine or with polyribosylribitol phosphate conjugated with diphtheria toxoid.
Decker MD; Edwards KM; Bradley R; Palmer P
J Pediatr; 1993 Mar; 122(3):410-3. PubMed ID: 8441096
[TBL] [Abstract][Full Text] [Related]
40. Safety and immunogenicity of three doses of a Neisseria meningitidis A + C diphtheria conjugate vaccine in infants from Niger.
Campagne G; Garba A; Fabre P; Schuchat A; Ryall R; Boulanger D; Bybel M; Carlone G; Briantais P; Ivanoff B; Xerri B; Chippaux JP
Pediatr Infect Dis J; 2000 Feb; 19(2):144-50. PubMed ID: 10694002
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
